LOGIN  |  REGISTER
Assertio
Surmodics

MultiPlan Announces Participation at Upcoming Conferences

April 30, 2024 | Last Trade: US$0.60 0.03 -5.01

NEW YORK / Apr 30, 2024 / Business Wire / MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”), a leading provider of technology and data-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that members of its management team will participate in person at the following conferences in May 2024:

  • Goldman Sachs Ninth Annual Leverage Finance and Credit Conference – Tuesday, May 14th, 2024, at the Terranea Resort, Rancho Palos Verde, CA
  • Bank of America Healthcare Conference – Wednesday, May 15, 2024, at the Encore Wynn, Las Vegas, NV (including a fireside chat at approximately 5:20 pm Eastern Time)
  • Barclays Leverage Finance Conference – Tuesday, May 21, 2024, at the Omni Barton Creek, Austin, TX

It is expected that current trends and first quarter 2024 performance will be discussed.

A live webcast and audio archive of the fireside chat at the Bank of America Healthcare Conference, if available, may be accessed through the investor relations section of MultiPlan’s website at investors.multiplan.us/events-and-presentations. Individuals who listen to the event will be presumed to have read MultiPlan’s recent filings with the Securities and Exchange Commission. Following the presentation, a webcast replay will be available for 30 days.

About MultiPlan

MultiPlan is committed to bending the cost curve in healthcare by delivering transparency, fairness, and affordability to the US healthcare system. Our focus is on identifying medical savings, helping to lower out-of-pocket costs, and reducing or eliminating balance billing for healthcare consumers. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets customers’ needs and customizes innovative solutions that combine its payment and revenue integrity, network-based, data and decision science, and analytics-based services. MultiPlan delivers value to more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit multiplan.com.

Recursion

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB